European Medicines Agency reviews the availability of emergency use in individual countries before approval for Celltrion Corona treatment
[김창수의 e뉴스 브리핑] Celltrion’Rekirona’ initiated emergency use review before product approval by the European Medicines Agency, etc.
Hanmi Pharmaceutical’s new anticancer drug,’Orasol,’ for breast cancer treatment, postponed marketing approval in the US